Elicera Therapeutics AB
F:8E8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Elicera Therapeutics AB
F:8E8
|
SE |
|
5
|
5E Advanced Materials Inc
NASDAQ:FEAM
|
US |
|
U
|
Unlimited Travel Group UTG AB (publ)
STO:UTG
|
SE |
|
S
|
Seven West Media Ltd
F:WA7
|
AU |
|
V
|
Venus Concept Inc
F:0RR1
|
CA |
|
Astra International Tbk PT
F:ASJ
|
ID |
Wall St Price Targets
Price Targets Summary
Elicera Therapeutics AB
According to Wall Street analysts, the average 1-year price target for Elicera Therapeutics AB is 1.3652 EUR with a low forecast of 1.2632 EUR and a high forecast of 1.4975 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Elicera Therapeutics AB's stock price target?
Price Target
1.3652
EUR
According to Wall Street analysts, the average 1-year price target for Elicera Therapeutics AB is 1.3652 EUR with a low forecast of 1.2632 EUR and a high forecast of 1.4975 EUR.
What is the Revenue forecast for Elicera Therapeutics AB?
Projected CAGR
80%
Over the last 4 years, the compound annual growth rate for Revenue has been 1 060%. The projected CAGR for the next 3 years is 80%.
